Trajectories of Cognitive Complaints in Patients With Breast Cancer and Their Association With Psychosocial and Neurobiological Factors
- PMID: 40772479
- PMCID: PMC12329573
- DOI: 10.1002/cam4.71130
Trajectories of Cognitive Complaints in Patients With Breast Cancer and Their Association With Psychosocial and Neurobiological Factors
Abstract
Introduction: Cancer-related cognitive impairment (CRCI) is common among patients with breast cancer, with significant variability in both severity and duration of cognitive complaints. This study aimed to elucidate this variability by identifying distinct trajectories of cognitive complaints over time in patients with breast cancer. Additionally, we explored the relationships between these trajectories and various clinical, demographic, psychosocial, neuropsychological, neuroimaging (resting-state functional MRI, rs-fMRI), and serum markers.
Methods: In this prospective study, 67 patients with non-metastatic breast cancer underwent psychosocial questionnaires, neuropsychological testing, rs-fMRI, and serum markers at diagnosis (T0), 8 months after diagnosis (T1), and 16 months after diagnosis (T2). Using the partition around medoids (PAM) algorithm on the difference scores of cognitive complaints, patients were clustered into distinct groups. Differences between the groups were assessed using linear mixed effects models. Rs-fMRI was analyzed using whole-brain graph theory and connectivity in four cognition-related networks.
Results: Four different trajectories of cognitive complaints were identified: stable with no changes in complaints (n = 24), improving with a decrease in complaints at T1 (n = 15), a short-term affected with an increase in complaints at T1 and recovery at T2 (n = 13), and a long-term affected with an increase in complaints at T1 and T2 (n = 15). While the groups strongly correlated with changes in the psychosocial measures, only subtle associations were found with neuropsychological tests, serum markers, or rs-fMRI analyses.
Conclusions: This research affirmed the presence of distinct trajectories of cognitive complaints in patients with breast cancer, which were associated with differences in anxiety, fatigue, stress, and depression.
Keywords: CRCI; Rs‐fMRI breast cancer; clustering; cognitive complaints; longitudinal trajectories; psychosocial.
© 2025 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Specialist breast care nurses for support of women with breast cancer.Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD005634. doi: 10.1002/14651858.CD005634.pub3. Cochrane Database Syst Rev. 2021. PMID: 34559420 Free PMC article.
-
Predicting cognitive decline: Deep-learning reveals subtle brain changes in pre-MCI stage.J Prev Alzheimers Dis. 2025 May;12(5):100079. doi: 10.1016/j.tjpad.2025.100079. Epub 2025 Feb 6. J Prev Alzheimers Dis. 2025. PMID: 39920001 Free PMC article.
-
Mild cognitive impairment is not predictive of dementia up to 15 years after subthalamic deep brain stimulation in Parkinson's disease.J Parkinsons Dis. 2025 Jun;15(4):879-891. doi: 10.1177/1877718X251334049. Epub 2025 May 20. J Parkinsons Dis. 2025. PMID: 40390641
-
Pseudo-Resting-State Functional MRI Derived from Dynamic Susceptibility Contrast Perfusion MRI Can Predict Cognitive Impairment in Glioma.AJNR Am J Neuroradiol. 2024 Oct 3;45(10):1552-1561. doi: 10.3174/ajnr.A8327. AJNR Am J Neuroradiol. 2024. PMID: 38719607
-
Prognostic factors for return to work in breast cancer survivors.Cochrane Database Syst Rev. 2025 May 7;5(5):CD015124. doi: 10.1002/14651858.CD015124.pub2. Cochrane Database Syst Rev. 2025. PMID: 40331515 Review.
References
-
- Giaquinto A. N., Sung H., Miller K. D., et al., “Breast Cancer Statistics, 2022,” CA: A Cancer Journal for Clinicians 72, no. 6 (2022): 524–541. - PubMed
-
- Sung H., Ferlay J., Siegel R. L., et al., “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians 71, no. 3 (2021): 209–249. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous